Introduction
The ␣ 2 ␤ 1 integrin serves as a receptor for a number of matrix and nonmatrix ligands, including collagens and a family of immune modulatory ligands, C1q and the collectin family of proteins. The integrin plays an important role in the innate immune response to infectious agents [1] [2] [3] [4] . Initially, we demonstrated that ␣ 2 ␤ 1 integrin expression by peritoneal mast cells (PMCs) is required for early, acute inflammatory responses to Listeria monocytogenes [5] . In earlier studies we demonstrated that the ␣ 2 ␤ 1 integrin is expressed at high levels on PMCs but not on bone marrow-derived mast cells (BMMCs) and recognizes the C1q complement protein in an immune complex containing Listeria [1, 5] . We recently described a novel pathway for mast cell activation mediated by cross talk between the ␣ 2 ␤ 1 integrin and the hepatocyte growth factor/c-met [6] . The engagement of both recep-tors was required for mast cell activation, rapid interleukin-6 (IL-6) secretion in vitro and in vivo, and neutrophil recruitment in vivo.
Although mast cells are primarily known for their function as mediators of IgE-mediated immediate hypersensitivity, they are also appreciated as versatile cells of the immune system, contributing to the innate and adaptive defense against external insults as well as to allergic responses [1, [7] [8] [9] [10] [11] [12] [13] . The best characterized pathway for mast cell secretion is the compound degranulation that occurs following cross-linking of the high-affinity Fc RI with IgE antibodies and specific antigens [14] . IgE cross-linking leads to the calcium-dependent release of preformed mediators, including histamine and serotonin [8, 10, 15] . IgE cross-linking initiates a sequence of downstream signals that lead to cytoskeletal reorganization, granulegranule fusion, granule docking with the plasma membrane, and the release of soluble mediators [16, 17] . A number of recent studies have elucidated the complexity of mast cell secretion and the selective release of granules [18] . Puri and Roche [18] demonstrated that BMMCs possess 2 distinct secretory granules, i.e. one that contains histamine and ␤ -hexosaminidase and a second that contains serotonin and cathepsin D. Although Fc RI crosslinking results in the release of both granule subsets, the secretion is mediated by distinct SNARE isoforms. Here, we demonstrate that mast cells can be activated by L. monocytogenes and secrete IL-6 in an ␣ 2 ␤ 1 integrin-and c-met-dependent, but IgE-independent, manner. The selective release of IL-6 and other cytokines selectively activates innate immunity without stimulation of the detrimental consequences associated with allergy.
To determine the mechanism of ␣ 2 ␤ 1 integrin-and c-met-dependent IL-6 secretion, we compared the response of PMC activation resulting from exposure to Listeria opsonized by an immune complex to that of PMCs stimulated by IgE cross-linking. IL-6 was released from PMCs following stimulation by Listeria plus an immune complex at 1 h but not by IgE binding to a multivalent antigen within the same time frame. Moreover, in contrast to the classic response of PMC to IgE cross-linking, IL-6 secretion was Ca independent, occurred without the release of serotonin or histamine, and did not require de novo transcriptional or translational synthesis of IL-6. Our data demonstrate that pathways leading to PMC activation in response to IgE cross-linking are distinct from pathways leading to the secretion of preformed IL-6 secretion in response to Listeria , thus providing the host with the ability to selectively activate the innate immune system.
Materials and Methods

Mast Cell Preparations
Animals were housed in pathogen-free conditions at Vanderbilt University Medical Center in compliance with institutional IACUC regulations. ␣ 2 integrin subunit-deficient ( ␣ 2-/-) mice and their wild-type (WT) littermate controls on a C57BL/6 ! 129/Sv background were used at 6-20 weeks of age. PMCs were isolated from residential peritoneal exudates using Percoll gradient centrifugation ( ϳ 85% purity) [1] . Fetal skin-derived mast cells (FSMC) were generated as described previously [19] . Single cell suspensions of day-16 fetal trunk skin were generated by incubation in 0.25% trypsin in Hank's Balanced Salt Solution for 20 min at 37 ° C . After erythrocyte lysis with lysing buffer (0.15 m M NH 4 Cl, 1.0 m M KHCO 3 , and 0.1 m M Na 2 EDTA), cells were washed and seeded at 2 ! 10 4 cells/ml in FSMC media [RPMI1640, 10% FBS,10 m M NEAA, 10 m M sodium pyruvate, 0.01% penicillinstreptomycin, 25 m M HEPES buffer, 50 M 2-mercaptoethanol, and 10 ng/ml IL-3 and SCF (both from Peprotech, Rocky Hill, N.J., USA)]. After 10-14 days, nonadherent cells were assessed for the expression of c-kit and expression of the ␣ 2 ␤ 1 integrin. Cultures of FSMCs were used if more than 85% of the WT cells coexpressed c-kit and the ␣ 2 ␤ 1 integrin. Expression of c-kit or the ␣ 2 ␤ 1 integrin was carried out by flow cytometric analysis using the following antibodies (all from BD Biosciences, San Diego, Calif., USA): FITC-anti-CD117 (c-kit; 2B8) and PE-anti-CD49b (integrin subunit; HM ␣ 2).
In vitro Activation Assays
For in vitro mast cell activation by Listeria , purified PMCs (5 ! 10 4 cells/well) were incubated for 1 h at 37 ° C with a washed suspension of Listeria (1 ! 10 7 organisms) and with rabbit antiListeria antibody and 50% serum. To determine the activation by IgE cross-linking, cells (5 ! 10 4 ) were preloaded for 18 h with anti-DNP IgE (1 g/ml, SPE-7; Sigma-Aldrich, St. Louis, Mo., USA) in Tyrodes buffer (137 m M NaCl/11.9 m M NaHCO 3 /0.4 m M Na 2 HPO 4 /2.7 m M KCl/1.1 m M MgCl 2 /5.6 m M glucose, pH 7.3). The sensitized cells were washed twice in Tyrodes buffer and stimulated with 100 ng/ml DNP-HSA (Sigma-Aldrich) for the indicated time points. As noted, FSMCs were pretreated with actinomycin D (2 g/ml) or cycloheximide (20 M ) for 15 min or with brefeldin A (BFA; 1 g/ml), monensin (1 M ), or BAPTA (2.5 M ) for 30 min (all reagents from Sigma-Aldrich) prior to stimulation.
The concentration of IL-6 and IL1 ␤ (BD Biosciences) and histamine and serotonin (both from Fitzgerald Industries, Concord, Mass., USA) in cell-free supernatants were analyzed by ELISA as per the manufacturer's instructions. The degree of degranulation was determined by measuring the release of ␤ -hexosaminidase. The enzymatic activity of ␤ -hexosaminidase in supernatants and cell pellets solubilized with 1% Triton X-100 in Tyrode's buffer was measured with p -nitrophenyl N-acetyl-␤ -D-glucosaminide (Sigma-Aldrich) in 0.1 M sodium citrate (pH 4.5) for 60 min at 37 ° C. The reaction was stopped by the addition of 0.2 M glycine (pH 10.7). The release of the product, 4-p -nitrophenol, was detected by absorbance at 405 nm. The extent of degranulation was calculated by dividing the 4-p -nitrophenol absorbance in the supernatant by the sum of the absorbance in the supernatant and detergent-solubilized cell pellet. Calcium mobilization was determined as per the manufacturer's instructions (Molecular Devices, Sunnyvale, Calif., USA).
Mast Cell Fractionation
Fractionation of mast cells to isolate mast cell granules was performed using a washed preparation of 1 ! 10 7 FSMCs. The pellet was resuspended in PBS and submitted to 3 freeze/thaw cycles. The homogenate was sonicated and centrifuged at 1,850 g for 10 min to pellet nuclei [20] . The postnuclear supernatant (PNS) was separated on a 2-layer Percoll gradient of 10 ! sucrose and water with gradient densities of 1.05 and 1.12 (2 ml/layer). The gradient was layered in 5-ml polycarbonate ultracentrifugation tubes (Beckman, Fullerton, Calif., USA). After applying the PNS on top of the gradient, the samples were spun at 190,000 g for 50 min in a Sorvall Discovery 90SE ultracentrifuge using the AH650 rotor. Samples of 200 l were collected starting from the top of the gradient, and the concentration of IL-6, histamine, and serotonin in each fraction was determined by ELISA.
Immunofluorescence
FSMCs were incubated with 200 M 5-HT (Sigma-Aldrich) for 16 h, washed with PBS, fixed with 3% paraformaldehyde for 20 min, and washed and permeabilized with 0.05% Tween-20/PBS for 15 min. Cells were cytospun onto glass slides and blocked with 3% horse serum/PBS for 1 h at room temperature. Primary rabbit anti-mouse IL-6 antibody (US Biologicals, Swampscott, Mass., USA) and primary murine anti-5-HT serotonin antibody were added overnight at 4 ° C. Cells were then washed and treated with goat anti-mouse Alexa Fluor 488 and goat anti-rabbit Alexa Fluor 633 (Molecular Probes, Carlsbad, Calif., USA) for 1 h at room temperature. Cells were mounted and imaged with an LSM 510 META confocal microscope (Carl Zeiss Microimaging, Germany) and the images were processed using LSM ImageBrowser (Carl Zeiss Microimaging) software.
Results
To define the molecular mechanisms leading to ␣ 2 ␤ 1 integrin-and c-met-dependent PMC activation, we compared the time course, calcium requirement, and mediator release following either mast cell stimulation by Listeria plus an immune complex or IgE cross-linking. ␣ 2 ␤ 1 integrin-and c-met-dependent activation is unique to PMC since BMMCs are more immature and fail to express the ␣ 2 ␤ 1 integrin [19] . Mechanistic studies of mast cell activation required larger numbers of cells than mast cell purification from peritoneal fluid provided. Therefore, we generated connective tissue mast cells from murine fetal skin as previously described by Yamada et al. [19] . FSMCs had been shown to closely resemble the phenotype of connective tissue mast cells, including increased histamine content, the presence of heparin, degranulation in response to compound 48/80, and expression of high levels of the ␣ 2 ␤ 1 integrin. The ␣ 2 ␤ 1 integrin was expressed at a similar intensity in WT, but not ␣ 2-null, FSMCs, as expected from previous studies by our group and others ( fig. 1 a and as previously reported) [1, 19] . Therefore, the morphology and response to Listeria of FSMCs was compared to that of purified PMCs. FSMCs appeared morphologically identical to PMCs ( fig. 1 b) . Since all of our previous work was carried out using PMCs, we compared the response of WT and ␣ 2-null PMCs to that of WT and ␣ 2-null FSMCs following Listeria opsonized with an immune complex ( fig. 1 c) . Both FSMCs and PMCs from WT mice responded with the release of IL-6 in an ␣ 2 ␤ 1 integrin-dependent manner ( fig. 1 c) . Both FSMCs and PMCs from ␣ 2-null mice failed to secrete IL-6 in response to Listeria , demonstrating that PMCs and FSMCs behave in a similar manner ( fig. 1 c) . Therefore, FSMCs were used throughout this study.
IL-6 secretion and ␤ -hexosaminidase release (a measure of degranulation) by WT and ␣ 2-null FSMCs following activation with either opsonized Listeria or IgE cross-linking was analyzed. Listeria opsonized with an immune complex stimulated IL-6 secretion from WT FSMCs, but not ␣ 2-null FSMCs, as previously reported ( fig. 2 ) [5] . WT and ␣ 2-null FSMCs released similar low levels of ␤ -hexosaminidase in response to Listeria plus an immune complex. In contrast, IgE cross-linking failed to stimulate IL-6 secretion from either WT or ␣ 2-null FSMCs at 1 h but resulted in a robust, ␣ 2-independent release of ␤ -hexosaminidase at 1 h ( fig. 2 ). These results indicate that mature connective tissue mast cells rapidly secreted IL-6 in response to Listeria in an ␣ 2 ␤ 1 integrindependent manner. In contrast, IgE cross-linking failed to signal a rapid IL-6 release at this time point. Furthermore, degranulation in response to IgE cross linking was ␣ 2 ␤ 1 integrin independent. The ␣ 2-null FSMCs maintained an adequate secretory function in response to IgE cross-linking and were not defective in terms of mast cell secretion to other stimuli.
Mast cell degranulation following IgE cross-linking requires calcium mobilization, a crucial second messenger in downstream signaling events [14] . Calcium mobilization by WT or ␣ 2-null FSMCs in response to Listeria plus immune complex stimulation, IgE-cross-linking, or the calcium ionophore ionomycin was examined. Both WT and ␣ 2-null FSMCs mobilized calcium in a similar manner following stimulation with IgE cross-linking or ionomycin ( fig. 3 a, b) . In contrast, neither WT nor ␣ 2-null FSMCs mobilized calcium following Listeria plus immune complex stimulation ( fig. 3 b) , suggesting that IL-6 secretion in response to Listeria is calcium independent. To further examine the requirement of extracellular calcium mobilization for IL-6 secretion, FSMCs were activated by either IgE cross-linking or Listeria plus an im-mune complex in calcium-free and calcium-containing Hank's Balanced Salt Solution. Mast cell degranulation and histamine release stimulated by IgE cross-linking was inhibited in calcium-free media ( fig. 3 c) . Mast cells activated by Listeria plus an immune complex secreted IL-6 in the presence or absence of calcium ( fig. 3 d) . In addition, we inhibited intracellular calcium signaling with the calcium chelator BAPTA. Addition of BAPTA markedly reduced mast cell degranulation in response to IgE cross-linking ( fig. 3 e) . In contrast, there was no defect in Color version available online IL-6 secretion from WT FSMCs in response to Listeria plus an immune complex in the presence of BAPTA ( fig. 3 f) . These results demonstrate that calcium mobilization is not required for ␣ 2 ␤ 1 integrin-dependent IL-6 secretion but is required for degranulation in response to IgE cross-linking. Mast cell degranulation in response to IgE cross-linking occurs within 0-10 min of stimulation and results in the release of histamine and serotonin, granule-associated mediators responsible for the allergic responses of IgEmediated degranulation [21, 22] . Our earlier studies examined IL-6 secretion only after 1 h [1, 5, 6] . The time course of IL-6 secretion following stimulation with the Listeria immune complex was compared to the time course of histamine and serotonin secretion following IgE cross-linking ( fig. 4 a-c) . In response to Listeria plus an immune complex, WT, but not ␣ 2-null, FSMCs released low levels of IL-6 by 15 min. IL-6 secretion peaked after 30 min of stimulation ( fig. 4 a) . The IL-6 levels remained elevated for 60 min. Neither histamine nor serotonin was detected following the stimulation of WT or ␣ 2-null FSMCs with the Listeria immune complex ( fig. 4 b, c) . The release of IL-6 was not observed during the first hour following IgE cross-linking ( fig. 4 d) . In contrast, both WT and ␣ 2-null FSMCs released high levels of histamine and serotonin within 5-10 min of Fc R activation ( fig. 4 e, f) . The magnitude and kinetics of release by WT and ␣ 2-null FSMCs were identical. However, IL-6 was secreted at later time points following IgE cross-linking (see below
Histamine and serotonin are both preformed mediators and they are rapidly released upon IgE-stimulation. Although previous reports have demonstrated that IL-6 is synthesized de novo by mast cells, the rapid nature of IL-6 release in response to Listeria plus an immune complex suggested that IL-6 is also stored in the mast cell [23, 24] . To determine if IL-6 was preformed or rapidly synthesized following stimulation, transcription and translation were inhibited using actinomycin D and cycloheximide, respectively. Treatment of FSMCs with actinomycin D or cycloheximide failed to inhibit IL-6 release by WT FSMCs after 1 h of immune complex stimulation ( fig. 5 ). The lack of inhibition by actinomycin D and cycloheximide suggested that IL-6 is preformed and not synthesized de novo and that ␣ 2 ␤ 1 integrin-mediated mast cell activation results in the release of a preformed IL-6 pool. In contrast, IL-6 was not rapidly secreted following IgE cross-linking. However, IL-6 was synthesized de novo and released 12 h after IgE cross-linking, as previously reported [25, 26] . The de novo synthesis of IL-6 was inhibited by actinomycin D and cycloheximide.
To directly address the transport pathway for IL-6 secretion, we inhibited trans-Golgi protein transport with BFA or monensin. The release of histamine by IgE cross linking was not significantly inhibited by either BFA or monensin ( fig. 6 a) . As shown above, Listeria plus an immune complex failed to stimulate histamine release ( fig. 6 a) . In contrast, the ␣ 2 ␤ 1 integrin-dependent Listeria -stimulated release of IL-6 at 1 h was inhibited by both BFA and monensin ( fig. 6 b) . IgE cross-linking did not result in rapid secretion of IL-6 ( fig. 6 b) .
In our earlier report, WT mice, but not ␣ 2-null mice, responded to Listeria in vivo by producing not only IL-6 but also IL-1 ␤ . In the intact animal, IL-1 ␤ is secreted by mast cells as well as other cells of the innate immune system, including macrophages that reside within the peritoneal cavity. To determine if the in vivo cytokine response to Listeria was entirely a result of mast cell secre- 2+ was required for the release of significant amounts of ␤ -hexosaminidase. e , f WT FSMCs were preincubated for 15 min at 37 ° C with the calcium chelator BAPTA or media alone and then stimulated as described for c and d . Secretion of ␤ -hexosaminidase ( e ), but not IL-6 ( f ), was inhibited in the presence of BAPTA, as determined by ELISA on cell-free supernatants. Experiments were performed in duplicate and results are expressed as means 8 SEM. p values were determined using Student's t test ( * p ! 0.02). tion of the cytokines or a result of downstream activation of other cells, the secretion of IL-1 ␤ by FSMCs in response to Listeria plus an immune complex was analyzed in vitro. WT FSMCs secreted both IL-1 ␤ and IL-6 when stimulated with opsonized Listeria. In contrast, ␣ 2-null FSMCs failed to secrete either IL-1 ␤ or IL-6 ( fig. 7 a, c) . Therefore, IL-1 ␤ is directly secreted by FSMCs in response to Listeria in an integrin-dependent manner.
Based on the previous literature, the presence of preformed IL-6 in FSMCs was unexpected. To address whether integrin-dependent activation led to secretion of the entire storage pool of IL-6, the total cellular content of IL-6 in resting FSMCs was compared to FSMCs after integrin-mediated stimulation and the amount of secreted IL-6. As shown in figure 7 d, the entire pool of IL-6 in resting FSMCs was secreted following activation. After FSMC stimulation, the mast cells were devoid of detectable IL-6. The intracellular stores of IL-1 ␤ were partially but significantly depleted after activation ( fig. 7 b) .
Earlier studies demonstrated that de novo synthesized IL-6 is present in small vesicles distinct from the granules that contain tryptase in human umbilical cord blood-derived mast cells [18, 21, 27] . To characterize the distinct granule fraction, PNS from both WT and ␣ 2-null FSMCs were isolated and separated via Percoll-density separation based on granule size. The contents of each fraction were analyzed by ELISA for IL-6 and histamine concentration ( fig. 8 a, b) . IL-6 was enriched in a subset of fractions (fractions 5-7) representing the smaller-sized vesicles. Only low levels of IL-6 were detected in the remaining fractions. Histamine was primarily separated into high-density fractions, suggestive of larger-sized vesicles (fractions [16] [17] [18] [19] . Both WT and ␣ 2-null FSMCs demonstrated a similar distribution and quantity of IL-6 and histamine in the fractions. These data suggest that IL-6 and histamine are not only selectively released but also differentially stored in mast cells.
Using serotonin as a marker of mast cell granules, we employed confocal immunofluorescence microscopy to characterize the subcellular localization of IL-6 and serotonin in mast cell granules [18, 21, 27] . As seen in figure  8 c, IL-6 (green) was visualized in small vesicles located * diffusely throughout the cell, as well as in close proximity to the cytoplasm interface of the plasma membrane. Serotonin (red), on the other hand, was stored primarily in large granules and some smaller granules throughout the cell. In the merged image there is no overlap, demonstrating that serotonin and IL-6 were not colocalized. Taken together, these results demonstrate that mast cells store IL-6 and histamine in distinct and separate compartments that are selectively released in response to different stimuli.
Discussion
We have now defined an integrin-and c-met-dependent secretory pathway for the mast cell secretion of preformed IL-6 and IL-1 ␤ in response to L. monocytogenes [1, 5] . The preformed IL-6 was stored in a distinct mast cell vesicle that lacked histamine or serotonin. The vesicle localization of IL-6 in our study is similar to the localization of newly synthesized IL-6, as previously described by Kandere-Grzybowska et al. [28] . Our findings, however, demonstrate a novel, ␣ 2 ␤ 1 integrin-dependent pathway for mast cell stimulation distinct from the IgE-mediated secretion of mediators required for allergy and anaphylaxis. In addition, we demonstrate that preformed IL-6 resides within connective tissue mast cells, providing an immediate source for cytokine secretion. These data also demonstrate that, although IL-6 secretion in response to Listeria is dependent on the ␣ 2 ␤ 1 integrin, IgE crosslinking-induced mast cell activation and secretion of histamine and serotonin does not require the ␣ 2 ␤ 1 integrin.
Secretion of IL-6 from BMMCs in the absence of degranulation has been reported as part of the innate immune/inflammatory response to CpG-containing oligodeoxynucleotides, bacterial lipopolysaccharides, IL-1, SCF, and IgE cross-linking [23, [28] [29] [30] . In all of these studies, IL-6 was synthesized de novo and was not re- leased until 6-24 h after stimulation. The rapid time course of IL-6 release in WT mice following the introduction of Listeria in our model suggested that IL-6 was preformed and stored. The ability of PMCs to secrete IL-6 even when transcription and translation was inhibited by either actinomycin D or cycloheximide confirmed that the cytokine was preformed and stored within PMCs. As previously reported, IL-6 was secreted in response to IgE cross-linking, but only after 12 h, and required de novo transcription and translation [25, 26] . Earlier studies have demonstrated that IgE cross linking results in the transcriptional regulation of IL-6 via the NF-B pathway [26] . These data suggest that mast cell secretion of IL-6 is regulated by 2 distinct pathways. In one, IL-6 is transcriptionally regulated and secreted at later time points in response to IgE-cross-linking. In the other, IL-6 is stored in preformed pools and released upon specific stimuli.
For many years the primary role of mast cells was considered to be the rapid degranulation following IgE crosslinking that led to anaphylaxis [7] . Recent evidence suggests that mast cells play many roles in the innate and adaptive immune response [7, [31] [32] [33] . Our data support a mechanism whereby IL-6 is stored and secreted from a granule distinct from the granules containing serotonin or histamine. Recently, a detailed analysis of mast cell degranulation demonstrated that histamine and serotonin are secreted via the same mechanisms but from distinct granules [18] . The serotonin-and histamine-containing granules identified by Puri and Roche [18] were indistinguishable by size. Differential release of serotonin and histamine from these 2 otherwise indistinguishable larger granules required distinct modes of vesicle trafficking and different SNARE proteins, one requiring VAMP8 and one being independent of VAMP8 [18, 27] . In our studies using immunofluorescence confocal mi- croscopy, IL-6 was not stored in large granules but rather was stored in smaller vesicles. This was further confirmed by separating the granule populations on a 2-layer Percoll gradient. The localization of this preformed IL-6 in small vesicles is similar to earlier descriptions of the localization of IL-6 when synthesized de novo. Here, we demonstrate that a preformed pool of IL-6 can be released through activation of a distinct receptor, the ␣ 2 ␤ 1 integrin, via a calcium-independent pathway.
Previous work has shown that rapid IL-6 release in response to the nonspecific calcium ionophore A23187 is sensitive to the trans-Golgi network (TGN) inhibitors BFA and monensin [34] . Although ␣ 2 ␤ 1 integrin-and Listeria -mediated IL-6 secretion was calcium independent, secretion was sensitive to inhibition by these 2 wellcharacterized protein secretion inhibitors with defined mechanisms of action on TGN vesicular transport. In contrast, IgE-stimulated degranulation was insensitive to BFA or monensin. These data are in accordance with previous data that demonstrated that IgE-mediated mast cell degranulation is independent of classical protein exocytosis via the TGN [34] . Our results suggest that mast cells contain several distinct granule pools that have different requirements for the TGN which are stimulated for release by separate stimuli.
In addition to mast cells, platelets, NK cells, cytotoxic T cells, neutrophils, and endothelial cells express the ␣ 2 ␤ 1 integrin and contain granules rich in inflammatory cytokines, chemokines, and angiogenic stimulators. Platelets are activated upon stimulation with collagen through the ␣ 2 ␤ 1 integrin and its co-receptor, GPVI [35] . Cross-linking of the ␣ 2 ␤ 1 integrin on NK cells with an ␣ 2 ␤ 1 integrin-specific antibody resulted in decreased cell motility and diminished cellular cytotoxicity [36] . In addition, in a non-granule-containing CD4+ T cell subset, ␣ 2 ␤ 1 integrin-mediated adhesion to type I collagen enhanced IFN-␥ production by anti-CD3 antibody [37] . These observations suggest that ␣ 2 ␤ 1 integrin expression by multiple hematopoietic cell types may modulate the inflammatory/immune function of these cells.
In summary, our data define an ␣ 2 ␤ 1 integrin-dependent pathway that leads to the release of preformed and prestored IL-6 by connective tissue mast cells. The rapid secretion of IL-6 results in activation of the innate immune response to L. monocytogenes . We provide convincing evidence that the secretory pathway leading to IL-6 release in response to Listeria is different from the pathway leading to degranulation in response to IgE cross-linking. The data demonstrate an additional way and a new receptor by which mast cells serve as the sentinels of the innate immune response, poised at the surfaces first exposed to assault by the external environment [38] .
